1-Heptadecanoyl-2-hydroxy-sn-glycero-3-phosphocholine

1-Heptadecanoyl-2-hydroxy-sn-glycero-3-phosphocholine is an endogenous metabolite present in Blood that can be used for the research of Pregnancy and Sepsis[1][2][3].

Product Specifications

CAS Number

[50930-23-9]

UNSPSC

12352211

Target

Endogenous Metabolite

Type

Natural Products

Related Pathways

Metabolic Enzyme/Protease

Applications

COVID-19-immunoregulation

Field of Research

Inflammation/Immunology

Assay Protocol

https://www.medchemexpress.com/1-heptadecanoyl-2-hydroxy-sn-glycero-3-phosphocholine.html

Purity

99.0

Solubility

Methanol : ≥ 25 mg/mL

Smiles

CCCCCCCCCCCCCCCCC(OC[C@@H](O)COP(OCC[N+](C)(C)C)([O-])=O)=O

Molecular Formula

C25H52NO7P

Molecular Weight

509.66

References & Citations

[1]Bahado-Singh RO, et al. Metabolomic prediction of fetal congenital heart defect in the first trimester. Am J Obstet Gynecol. 2014 Sep;211 (3) :240.e1-240.e14. |[2]Ferrario M, et al. Mortality prediction in patients with severe septic shock: a pilot study using a target metabolomics approach. Sci Rep. 2016 Feb 5;6:20391. |[3]Lee N, et al. Endogenous toxic metabolites and implications in cancer therapy. Oncogene. 2020 Aug;39 (35) :5709-5720.